国家放射与治疗临床医学研究中心与香港医院管理局签署三年合作备忘录

国家放射与治疗临床医学研究中心与香港医院管理局签署三年合作备忘录

国家放射与治疗临床医学研究中心与香港医院管理局于2025年9月6日共同签署为期三年的合作备忘录，双方将在胸痛中心与心血管疾病专病中心的标准化建设、人才交流与培训，以及公众教育等多方面加强合作，携手推进心血管疾病防治的规范化建设与协同发展，共同提升区域医疗水平。

国家放射与治疗临床医学研究中心主任葛均波院士与香港医管局行政总裁李夏茵医生代表双方签署合作备忘录。

葛均波院士期望，通过签署合作备忘录，进一步提升双方的友好合作关系，共同推动两地在有关医学领域的发展。葛院士表示︰“我们期待日后与医管局在心血管疾病专病中心建设、人才培训、临床与科研创新等多方面携手共进，共同提升心血管医疗服务的水平，造福两地的病人。”

李夏茵医生说：“我期望此次签署合作备忘录能进一步深化内地和香港在防治心血管疾病的合作伙伴关系，并为推进心血管疾病领域的科研创新与临床应用提供坚实基础，携手促进内地和香港医疗技术的全面提升。”

国家放射与治疗临床医学研究中心为中国首个介入医学领域的国家级临床研究中心。中心聚焦泛血管疾病的介入诊疗技术研发与临床应用，并积极响应健康中国2030的战略目标，推动高品质医疗创新、技术标准化及全国协同合作。

未来，国家放射与治疗临床医学研究中心与香港医管局将共同规划及落实不同合作项目，着力推动临床诊疗、科研创新及医疗人才培育的发展，进一步促进双方在心血管疾病防治领域的协同发展，惠及更多患者。

△现场照片

National Clinical Research Center for Interventional Medicine and Hospital Authority signed three-year memorandum of understanding

On September 6, 2025, the National Clinical Research Center for Interventional Medicine and the Hospital Authority (HA) signed a three-year memorandum of understanding (MOU) to strengthen collaboration in multiple areas, including the establishment of Chest Pain Centers and Cardiovascular Diseases Centers, health talent exchange and public education. The MOU is expected to foster standardisation of clinical management for cardiovascular diseases and achieve higher regional medical standards through joint efforts.

The MOU was signed by the Director of the National Clinical Research Center for Interventional Medicine, Academician Professor Ge Junbo and the HA Chief Executive, Dr Libby Lee.

Professor Ge Junbo expressed his aspiration to further enhance the close partnership with the HA through signing the MOU and jointly promote the development of cardiology field in the Mainland and Hong Kong. Professor Ge said, “We look forward to working together with the HA in various areas to enhance the quality of cardiovascular care, particularly in the development of cardiovascular diseases centers, talent exchange, clinical and research innovation for the well-being of patients in both places.”

Dr Libby Lee said, “It is expecting that the signing of this MOU could further deepen the Mainland and Hong Kong’s collaboration partnership on cardiovascular diseases, could lay a solid foundation for advance technologies in cardiology field and could jointly elevate medical standards across the Mainland and Hong Kong.”

The National Clinical Research Center for Interventional Medicine was China’s first national clinical research center specialising in interventional medicine. The Center focuses on the research and development of interventional medicine for pan-vascular diseases and actively responds to the strategic goals of Healthy China 2030, promoting high-quality medical innovation, standardisation of clinical practice and national collaboration.

Moving forward, the National Clinical Research Center for Interventional Medicine and the HA will jointly plan and implement a range of collaborative initiatives, focusing on advancing clinical management, fostering research innovation, and nurturing medical talent. This partnership will further promote the coordinated development of cardiovascular disease prevention and treatment, yielding lasting benefits for a wider patient community.

全面工作

传播矩阵

FOLLOW US

• 苏州工业园区东方华夏心血管健康研究院

• 电话：0512-68295918

• 邮箱：info@ccahouse.org

• 网址：https://www.ccahouse.org

• 地址：苏州工业园区水坊路36号姑苏会平江馆心脏之家